Skip to main content

Endoscopic Management of Barrett’s Esophagus

  • Chapter
  • First Online:
Diagnostic and Therapeutic Procedures in Gastroenterology

Abstract

Barrett’s esophagus (BE) is a well-recognized premalignant condition for development of esophageal adenocarcinoma (EAC). It is defined as the displacement of the squamo-columnar junction proximal to the gastroesophageal junction, with the presence of intestinal metaplasia (IM) on biopsies (Wang and Sampliner 2008; Sharma et al. 2004). Chronic gastroesophageal reflux disease (GERD) is the most frequent identifiable risk factor for Barrett’s esophagus (Wang and Sampliner 2008; Sharma et al. 2004). In Western populations, BE may be present in approximately 0.4–1.6% of adults, whereas in patients with chronic GERD, the prevalence is approximately 10–15% (Pondugula et al. 2007; Wani and Sharma 2007a). The frequency of EAC in the United States is gradually rising. It has been estimated that 14,550 new cases of esophageal cancer were diagnosed in 2006, with 13,770 deaths related to esophageal cancer, the majority diagnosed at an advanced stage (American Cancer Society 2006). Barrett’s esophagus is considered to be one of the most important identifiable risk factors leading to development of EAC (Menke-Pluymers et al. 1993; Solaymani-Dodaran et al. 2004). Progression of BE to esophageal cancer involves a series of pathological changes, from early nondysplastic columnar epithelium (ND BE) to low-grade dysplasia (LGD), high-grade dysplasia (HGD), and finally to cancer. The mortality associated with EAC is high, with a 5-year survival rate of only 15% (Pondugula et al.2007; Cossentino and Wong 2003; Devesa et al.1998).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • American Cancer Society. American cancer society: cancer facts and figures 2006. Atlanta: American Cancer Society; 2006.

    Google Scholar 

  • Breyer HP, Silva De Barros SG, Maguilnik I, et al. Does methylene blue detect intestinal metaplasia in Barrett’s esophagus? Gastrointest Endosc. 2003;57:505–9.

    Article  PubMed  Google Scholar 

  • Buttar NS, Wang KK, Sebo TJ, et al. Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterology. 2001;120(7):1630–9.

    Article  PubMed  CAS  Google Scholar 

  • Cameron AJ, Carpenter HA. Barrett’s esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol. 1997;92(4):586–91.

    PubMed  CAS  Google Scholar 

  • Canto MI, Setrakian S, Willis JE, et al. Methylene blue staining of dysplastic and nondysplastic Barrett’s esophagus: an in vivo and ex vivo study. Endoscopy. 2001;33:391–400.

    Article  PubMed  CAS  Google Scholar 

  • Chak A, Canto M, Stevens PD, et al. Clinical applications of a new through-the-scope ultrasound probe: prospective comparison with an ultrasound endoscope. Gastrointest Endosc. 1997;45(3):291–5.

    Article  PubMed  CAS  Google Scholar 

  • Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA. Surveillance and survival in Barrett’s adenocarcinomas: a population-based study. Gastroenterology. 2002;122(3):633–40.

    Article  PubMed  Google Scholar 

  • Cossentino MJ, Wong RK. Barrett’s esophagus and risk of esophageal adenocarcinoma. Semin Gastrointest Dis. 2003;14(3):128–35.

    PubMed  Google Scholar 

  • Curvers WL, Singh R, Wong Kee Song LM, et al. Endoscopic tri-modal imaging for detection of early neoplasia in Barrett’s oesophagus; a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system. Gut. 2008a;57:167–72.

    Article  PubMed  CAS  Google Scholar 

  • Curvers W, Rosmolen W, Elzer B, et al. Low grade intraepithelial neoplasia in Barrett’s esophagus: overdiagnosed but underestimated. Gastrointest Endosc. 2008b;67(5):M1324.

    Article  Google Scholar 

  • Das A, Singh V, Fleischer DE, Sharma VK. A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol. 2008;103(6):1340–5.

    Article  PubMed  Google Scholar 

  • Devesa SS, Blot WJ, Fraumeni Jr JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83(10):2049–53.

    Article  PubMed  CAS  Google Scholar 

  • Dresner SM, Griffin SM, Wayman J, et al. Human model of duodenogastro-oesophageal reflux in the development of Barrett’s metaplasia. Br J Surg. 2003;90(9):1120–8.

    Article  PubMed  CAS  Google Scholar 

  • Dulai GS, Shekelle PG, Jensen DM, et al. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett’s cohort. Am J Gastroenterol. 2005;100(4):775–83.

    Article  PubMed  Google Scholar 

  • Ell C, May A, Pech O, Gossner L, et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointest Endosc. 2007;65(1):3–10.

    Article  PubMed  Google Scholar 

  • Eloubeidi MA, Provenzale D. Does this patient have Barrett’s esophagus? The utility of predicting Barrett’s esophagus at the index endoscopy. Am J Gastroenterol. 1999;94(4):937–43.

    Article  PubMed  CAS  Google Scholar 

  • Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–52.

    Article  PubMed  CAS  Google Scholar 

  • Falk GW, Ours TM, Richter JE. Practice patterns for surveillance of Barrett’s esophagus in the United States. Gastrointest Endosc. 2000;52(2):197–203.

    Article  PubMed  CAS  Google Scholar 

  • Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett’s esophagus in asymptomatic individuals. Gastroenterology. 2002;123(2):461–7.

    Article  PubMed  Google Scholar 

  • Gondrie JJ, Pouw RE, Sondermeijer CM, et al. Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy. 2008;40(5):370–9.

    Article  PubMed  CAS  Google Scholar 

  • Gono K, Obi T, Yamaguchi M, et al. Appearance of enhanced tissue features in narrow-band endoscopic imaging. J Biomed Opt. 2004;9:568–77.

    Article  PubMed  Google Scholar 

  • Greenwald BD, Horwhat JD, Abrams J, Lightdale CJ, Dumot J. Endoscopic cryotherapy ablation is safe and well-tolerated in Barrett’s esophagus, esophageal dysplasia, and esophageal cancer. Gastrointest Endosc. 2008;67(5):AB76.

    Article  Google Scholar 

  • Guelrud M, Herrera I. Acetic acid improves identification of remnant islands of Barrett’s epithelium after endoscopic therapy. Gastrointest Endosc. 1998;47:512–5.

    Article  PubMed  CAS  Google Scholar 

  • Hanna S, Rastogi A, Weston AP, Totta F, Schmitz R, Mathur S, et al. Detection of Barrett’s esophagus after endoscopic healing of erosive esophagitis. Am J Gastroenterol. 2006;101(7):1416–20.

    Article  PubMed  Google Scholar 

  • Heitmiller RF, Redmond M, Hamilton SR. Barrett’s esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg. 1996;224(1):66–71.

    Article  PubMed  CAS  Google Scholar 

  • Horwhat JD, Maydonovitch CL, Ramos F, et al. A randomized comparison of methylene blue-directed biopsy versus conventional four-quadrant biopsy for the detection of intestinal metaplasia and dysplasia in patients with long-segment Barrett’s esophagus. Am J Gastroenterol. 2008;103(3):546–54.

    Article  PubMed  Google Scholar 

  • Kahrilas PJ, Shaheen NJ, Vaezi MF, et al. American Gastroenterological Association. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135(4):1383–91.

    Article  PubMed  Google Scholar 

  • Kantsevoy SV, Cruz-Correa MR, Vaughn CA, Jagannath SB, Pasricha PJ, Kalloo AN. Endoscopic cryotherapy for the treatment of bleeding mucosal vascular lesions of the GI tract: a pilot study. Gastrointest Endosc. 2003;57(3):403–6.

    Article  PubMed  Google Scholar 

  • Kara MA, Smits ME, Rosmolen WD, et al. A randomized cross-over study comparing light-induced fluorescence endoscopy with standard video endoscopy for the detection of early neoplasia in Barrett’s esophagus. Gastrointest Endosc. 2005a;61:671–8.

    Article  PubMed  Google Scholar 

  • Kara MA, Peters FP, Rosmolen WD, et al. High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett’s esophagus: a prospective randomized crossover study. Endoscopy. 2005b;37:929–36.

    Article  PubMed  CAS  Google Scholar 

  • Kara MA, Peters FP, Ten Kate FJW, et al. Endoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett’s esophagus. Gastrointest Endosc. 2005c;61:679–85.

    Article  PubMed  Google Scholar 

  • Kara MA, Ennahachi M, Fockens P, et al. Detection and classification of the mucosal and vascular patterns (mucosal morphology) in Barrett’s esophagus by using narrow band imaging. Gastrointest Endosc. 2006a;64:155–66.

    Article  PubMed  Google Scholar 

  • Kara MA, Peters FP, Fockens P, et al. Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett’s esophagus. Gastrointest Endosc. 2006b;64:176–85.

    Article  PubMed  Google Scholar 

  • Kiesslich R, Gossner L, Goetz M, et al. In vivo histology of Barrett’s esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol. 2006;4:979–87.

    Article  PubMed  Google Scholar 

  • Konda VJ, Ross AS, Ferguson MK, et al. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett’s esophagus overestimated? Clin Gastroenterol Hepatol. 2008;6(2):159–64.

    Article  PubMed  Google Scholar 

  • Larghi A, Lightdale CJ, Memeo L, Bhagat G, Okpara N, Rotterdam H. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett’s esophagus. Gastrointest Endosc. 2005;62(1):16–23.

    Article  PubMed  Google Scholar 

  • Lightdale CJ. Esophageal cancer. American College of Gastroenterology. Am J Gastroenterol. 1999;94(1):20–9.

    Article  PubMed  CAS  Google Scholar 

  • Lim CH, Rotimi O, Dexter SP, Axon AT. Randomized crossover study that used methylene blue or random 4-quadrant biopsy for the diagnosis of dysplasia in Barrett’s esophagus. Gastrointest Endosc. 2006;64(2):195–9.

    Article  PubMed  Google Scholar 

  • Lim CH, Treanor D, Dixon MF, Axon AT. Low-grade dysplasia in Barrett’s esophagus has a high risk of progression. Endoscopy. 2007;39(7):581–7.

    Article  PubMed  CAS  Google Scholar 

  • Mallery S, Van Dam J. EUS in the evaluation of esophageal carcinoma. Gastrointest Endosc. 2000;52(6 Suppl):S6–11.

    Article  PubMed  CAS  Google Scholar 

  • Meining A, Rösch T, Kiesslich R, Muders M, Sax F, Heldwein W. Inter- and intra-observer variability of magnification chromoendoscopy for detecting specialized intestinal metaplasia at the gastroesophageal junction. Endoscopy. 2004;36(2):160–4.

    Article  PubMed  CAS  Google Scholar 

  • Menke-Pluymers MB, Hop WC, Dees J, van Blankenstein M, Tilanus HW. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer. 1993;72(4):1155–8.

    Article  PubMed  CAS  Google Scholar 

  • Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol. 2001a;32(4):368–78.

    Article  PubMed  CAS  Google Scholar 

  • Montgomery E, Goldblum JR, Greenson JK, et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol. 2001b;32(4):379–88.

    Article  PubMed  CAS  Google Scholar 

  • Nelson DB, Block KP, Bosco JJ, et al. High resolution and high-magnification endoscopy: September 2000. Gastrointest Endosc. 2000;52(6 Pt 1):864–6.

    Article  PubMed  Google Scholar 

  • Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett’s esophagus. Gastrointest Endosc. 2000;52(3):328–32.

    Article  PubMed  CAS  Google Scholar 

  • O’Connor JB, Falk GW, Richter JE. The incidence of adenocarcinoma and dysplasia in Barrett’s esophagus: report on the Cleveland Clinic Barrett’s Esophagus Registry. Am J Gastroenterol. 1999;94(8):2037–42.

    PubMed  Google Scholar 

  • Olliver JR, Wild CP, Sahay P, Dexter S, Hardie LJ. Chromoendoscopy with methylene blue and associated DNA damage in Barrett’s oesophagus. Lancet. 2003;362(9381):373–4.

    Article  PubMed  CAS  Google Scholar 

  • Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients. Gastrointest Endosc. 1999;49:1–7.

    Article  PubMed  CAS  Google Scholar 

  • Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett’s esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc. 2003;58(2):183–8.

    Article  PubMed  Google Scholar 

  • Overholt BF, Wang KK, Burdick JS, et al. International Photodynamic Group for High-Grade Dysplasia in Barrett’s Esophagus. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett’s high-grade dysplasia. Gastrointest Endosc. 2007;66(3):460–8.

    Article  PubMed  Google Scholar 

  • Pasricha PJ, Hill S, Wadwa KS, et al. Endoscopic cryotherapy: experimental results and first clinical use. Gastrointest Endosc. 1999;49(5):627–31.

    Article  PubMed  CAS  Google Scholar 

  • Pech O, Behrens A, May A, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut. 2008;57(9):1200–6.

    Article  PubMed  CAS  Google Scholar 

  • Peters FP, Kara MA, Rosmolen WD, et al. Stepwise radical endoscopic resection is effective for complete removal of Barrett’s esophagus with early neoplasia: a prospective study. Am J Gastroenterol. 2006;101(7):1449–57.

    Article  PubMed  Google Scholar 

  • Pohl H, Rosch T, Vieth M, et al. Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett’s esophagus. Gut. 2008 Oct;57(12):1648–53.

    Article  PubMed  CAS  Google Scholar 

  • Pondugula K, Wani S, Sharma P. Barrett’s esophagus and esophageal adenocarcinoma in adults: long-term GERD or something else? Curr Gastroenterol Rep. 2007;9(6):468–74.

    Article  PubMed  Google Scholar 

  • Pouw RE, Gondrie JJ, Sondermeijer CM, et al. Eradication of Barrett Esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection. J Gastrointest Surg. 2008;12(10):1627–36.

    Article  PubMed  Google Scholar 

  • Prasad GA, Wang KK, Buttar NS, et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett’s esophagus. Gastroenterology. 2007;132(4):1226–33.

    Article  PubMed  Google Scholar 

  • Raju GS, Ahmed I, Xiao SY, Brining D, Bhutani MS, Pasricha PJ. Graded esophageal mucosal ablation with cryotherapy, and the protective effects of submucosal saline. Endoscopy. 2005;37(6):523–6.

    Article  PubMed  CAS  Google Scholar 

  • Rastogi A, Puli S, El-Serag HB, Bansal A, Wani S, Sharma P. Incidence of esophageal adenocarcinoma in patients with Barrett’s esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc. 2008;67(3):394–8.

    Article  PubMed  Google Scholar 

  • Sampliner RE, Fennerty B, Garewal HS. Reversal of Barrett’s esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc. 1996;44(5):532–5.

    Article  PubMed  CAS  Google Scholar 

  • Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett’s esophagus? Gastroenterology. 2000;119(2):333–8. Review.

    Article  PubMed  CAS  Google Scholar 

  • Shaheen N, Sharma P, Overholt BF, et al. A randomized, multicenter, sham-controlled trial of radiofrequency ablation (RFA) for subjects with Barrett’s esophagus (BE) containing dysplasia: interim results of the Aim Dysplasia Trial. Gastroenterology. 2008;132:A-37.

    Article  Google Scholar 

  • Sharma P, Topalovski M, Mayo MS, et al. Methylene blue chromoendoscopy for detection of shortsegment Barrett’s esophagus. Gastrointest Endosc. 2001;54:289–93.

    Article  PubMed  CAS  Google Scholar 

  • Sharma P, Weston AP, Topalovski M, et al. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett’s oesophagus. Gut. 2003;52:24–7.

    Article  PubMed  CAS  Google Scholar 

  • Sharma P, McQuaid K, Dent J, Fennerty MB, Sampliner R, et al. A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop. Gastroenterology. 2004;127(1):310–30.

    Article  PubMed  Google Scholar 

  • Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006a;131(5):1392–9.

    Article  PubMed  Google Scholar 

  • Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE. Dysplasia and cancer in a large multicenter cohort of patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2006b;4(5):566–72.

    Article  PubMed  Google Scholar 

  • Sharma P, Bansal A, Mathur S, et al. The utility of a novel narrow band imaging endoscopy system in patients with Barrett’s esophagus. Gastrointest Endosc. 2006c;64:167–75.

    Article  PubMed  Google Scholar 

  • Sharma VK, Wang KK, Overholt BF, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett’s esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc. 2007a;65:185–95.

    Article  PubMed  Google Scholar 

  • Sharma P, Wani S, Rastogi A. Endoscopic therapy for high-grade dysplasia in Barrett’s esophagus: ablate, resect, or both? Gastrointest Endosc. 2007b;66(3):469–74.

    Article  PubMed  Google Scholar 

  • Shumaker DA, de Garmo P, Faigel DO. Potential impact of preoperative EUS on esophageal cancer management and cost. Gastrointest Endosc. 2002;56(3):391–6.

    Article  PubMed  Google Scholar 

  • Skacel M, Petras RE, Gramlich TL, Sigel JE, Richter JE, Goldblum JR. The diagnosis of low-grade dysplasia in Barrett’s esophagus and its implications for disease progression. Am J Gastroenterol. 2000;95(12):3383–7.

    Article  PubMed  CAS  Google Scholar 

  • Solaymani-Dodaran M, Logan RF, West J, Card T, Coupland C. Risk of oesophageal cancer in Barrett’s oesophagus and gastro-oesophageal reflux. Gut. 2004;53(8):1070–4.

    Article  PubMed  CAS  Google Scholar 

  • Van Laethem JL, Peny MO, Salmon I, Cremer M, Devière J. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett’s oesophagus. Gut. 2000;46(4):574–7.

    Article  PubMed  Google Scholar 

  • Wang KK, Sampliner RE. Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol. 2008;103(3):788–97.

    Article  PubMed  Google Scholar 

  • Wani S, Sharma P. Management of dysplasia in Barrett’s esophagus. Curr GERD Rep. 2007a;1(4):248–55.

    Article  Google Scholar 

  • Wani S, Sharma P. Endoscopic surface imaging of Barrett’s Esophagus: an optimistic view. Gastroenterology. 2007b;133(1):11–3.

    Article  PubMed  Google Scholar 

  • Wani S, Puli SR, Shaheen NJ, et al. Esophageal adenocarcinoma in Barrett’s esophagus post endoscopic ablative therapy: a meta-analysis and systemic review. Am J Gastroenterol. 2009;104:502–13.

    Article  PubMed  Google Scholar 

  • Wolfsen HC, Crook JE, Krishna M, et al. Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett’s Esophagus. Gastroenterology. 2008;135(1):24–31.

    Article  PubMed  Google Scholar 

  • Yao K, Takaki Y, Ohara J, et al. Magnification endoscopy outlines the microvascular architecture and extent of Barrett’s intramucosal carcinoma prior to endoscopic resection. Gastrointest Endosc. 2006;63:1064–10.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mandeep Singh M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Singh, M., Wani, S., Sharma, P. (2011). Endoscopic Management of Barrett’s Esophagus. In: Wu, G., Sridhar, S. (eds) Diagnostic and Therapeutic Procedures in Gastroenterology. Clinical Gastroenterology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59745-044-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-044-7_2

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-58829-478-4

  • Online ISBN: 978-1-59745-044-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics